Yuki Nakanishi Selected Research

phenylalanylphenylalanylamide

10/2011

The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuki Nakanishi Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 09/2011
7	Carcinogenesis 11/2021 - 07/2013
4	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 09/2011
3	Abscess 05/2021 - 01/2021
3	Hyperalgesia 01/2017 - 01/2011
3	Inflammation (Inflammations) 01/2016 - 09/2011
2	Suppuration 03/2022 - 01/2021
2	Polyps 01/2022 - 09/2011
2	Wounds and Injuries (Trauma) 05/2021 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2013
2	Colitis 10/2019 - 10/2015
2	Intestinal Neoplasms (Intestinal Cancer) 12/2018 - 07/2013
2	Cough 02/2013 - 02/2011
1	Osteomyelitis 03/2022
1	Fever (Fevers) 03/2022
1	Low Back Pain (Lumbago) 03/2022
1	COVID-19 03/2022
1	Body Weight (Weight, Body) 03/2022
1	Dyspnea (Shortness of Breath) 03/2022
1	Edema (Dropsy) 03/2022
1	Heart Failure 03/2022
1	Infections 03/2022
1	Constrictive Pericarditis 03/2022
1	Duodenal Ulcer (Curling's Ulcer) 02/2022
1	Hemorrhage 02/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Lung Abscess 01/2021
1	Compression Fractures (Compression Fracture) 01/2021
1	Liver Neoplasms (Liver Cancer) 10/2020
1	Fasciitis (Fascitis) 11/2019
1	Adenocarcinoma 12/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017
1	Neuralgia (Stump Neuralgia) 01/2017
1	Intestinal Polyps 10/2015
1	Diabetic Neuropathies (Diabetic Neuropathy) 06/2014
1	Fatty Liver 01/2014

Drug/Important Bio-Agent (IBA)

4	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 01/2021
3	Calcibiotic Root Canal SealerIBA 01/2021 - 12/2018
3	nardilysinIBA 01/2018 - 05/2012
2	16S Ribosomal RNAIBA 03/2022 - 01/2021
2	Proton Pump InhibitorsIBA 01/2022 - 11/2019
2	InterferonsIBA 11/2021 - 12/2018
2	Dextran SulfateIBA 10/2019 - 07/2013
2	Proteins (Proteins, Gene)FDA Link 10/2015 - 05/2012
2	AzoxymethaneIBA 10/2015 - 07/2013
2	Sodium Channels (Sodium Channel)IBA 06/2014 - 02/2011
2	Fentanyl (Sublimaze)FDA LinkGeneric 06/2014 - 02/2013
2	Citric Acid (Citrate)FDA LinkGeneric 02/2013 - 02/2011
1	Cefazolin (Ancef)FDA LinkGeneric 03/2022
1	mRNA VaccinesIBA 03/2022
1	Immunoglobulin G (IgG)IBA 03/2022
1	Immunoglobulin M (IgM)IBA 03/2022
1	RNA (Ribonucleic Acid)IBA 03/2022
1	VaccinesIBA 03/2022
1	Nucleocapsid ProteinsIBA 03/2022
1	Pharmaceutical PreparationsIBA 02/2022
1	Bile Pigments (Bilin)IBA 01/2022
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2022
1	FluoroquinolonesIBA 01/2021
1	Recombinases (Recombinase)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Phosphotransferases (Kinase)IBA 10/2020
1	Histones (Histone)IBA 01/2020
1	MucinsIBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Histone MethyltransferasesIBA 01/2020
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2019
1	Tamoxifen FDA LinkGeneric 01/2019
1	PKC-3 proteinIBA 12/2018
1	src-Family KinasesIBA 12/2018
1	Doublecortin-Like KinasesIBA 12/2018
1	Metalloendopeptidases (Metalloendopeptidase)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	liu-jun-zi-tangIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Ghrelin ReceptorsIBA 01/2017
1	GhrelinIBA 01/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	Antimicrobial PeptidesIBA 01/2016
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2015
1	ONO-AE1-329IBA 10/2015
1	Dextrans (Dextran)FDA Link 10/2015
1	CateninsIBA 02/2015
1	Protein Kinase CIBA 02/2015
1	Streptozocin (Streptozotocin)FDA Link 06/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	LipopolysaccharidesIBA 07/2013
1	Histamine H1 AntagonistsIBA 02/2013
1	fexofenadine (Allegra)FDA LinkGeneric 02/2013
1	moguisteineIBA 02/2013
1	Histamine (Histamine Dihydrochloride)FDA Link 02/2013
1	LigandsIBA 01/2013
1	ChemokinesIBA 01/2013

Therapy/Procedure

6	Therapeutics 02/2022 - 01/2013
2	Lasers (Laser) 03/2022 - 01/2021
1	Injections 03/2022
1	Immunotherapy 11/2021
1	Thoracic Surgical Procedures 05/2021
1	Intravenous Administration 02/2013